Study Details

Back to Search Results

A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients with Fibromyalgia

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT03056690

Astellas Study ID

The unique identification code given by the study sponsor.

0819-CL-0201

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Fibromyalgia

Phase

These clinical trials are done to learn if an experimental treatment helps participants who have a specific condition or disease. Phase 2 trials usually include a larger group of participants than Phase 1 trials.

Phase 2

Age

18 years - 80 years

Sex

Female & Male

Product

ASP0819

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Mar 2017 - Feb 2018

Masking

Double (Participant, Investigator)

Enrollment number

186

A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients with Fibromyalgia

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients with Fibromyalgia? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Site US10055 - Central Kentucky Research Asc

Lexington, United States, 40509

Site US10059 - Hillcrest Clinical

Oklahoma City, United States, 73119

Site US10006 - Columbus Regional Research Ins

Columbus, United States, 31904

Site US10018 - Altea Research Institute

Las Vegas, United States, 89102

Site US10005 - Charlottesville Med Research

Charlottesville, United States, 22911

Site US10031 - Wake Research Associates

Raleigh, United States, 27612

Site US10012 - Palm Beach Research Center

West Palm Beach, United States, 33409

Site US10003 - Artemis Inst For Clin Research

San Diego, United States, 92103

Site US10037 - Dept of Psychiatry and Neuro University of Cincinnati

Cincinnati, United States, 45219

Site US10019 - Lillestol Research LLC

Fargo, United States, 58103

Site US10039 - Superior Research LLC

Sacramento, United States, 95831

Site US10028 - Renstar Medical Research

Ocala, United States, 34471

Site US10038 - Heartland Research Associates

Wichita, United States, 67205

Site US10024 - Compass Research LLC

Orlando, United States, 32806

Site US10010 - Upstate Clinical Research Asc

Williamsville, United States, 14221

Site US10032 - Peters Medical Research

High Point, United States, 27262

Site US10023 - Oregon Ctr for Clinical Invest

Salem, United States, 97301

Site US10045 - TriWest Research Associates

El Cajon, United States, 92020

Site US10025 - Achieve Clinical Research, LLC

Birmingham, United States, 35216

Site US10013 - Bateman Horne Center

Salt Lake City, United States, 84102

Site US10027 - BTC of New Bedford LLC

New Bedford, United States, 02740

Site US10056 - Atlanta Ctr for Med Research

Atlanta, United States, 30331

Site US10043 - Oregon Ctr for Clinical Invest

Portland, United States, 97214

Site US10048 - Diablo Clinical Research Inc

Walnut Creek, United States, 94598

Site US10035 - McIlwain Medical Research

Tampa, United States, 33614

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo